{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T15:36:28Z","timestamp":1767713788069,"version":"3.41.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,31]],"date-time":"2016-12-31T00:00:00Z","timestamp":1483142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.nrl.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T11:50:32Z","timestamp":1469793032000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dolor neurop\u00e1tico en pacientes oncol\u00f3gicos en tratamiento con bortezomib"],"prefix":"10.1016","volume":"33","author":[{"given":"S.","family":"Exp\u00f3sito Vizca\u00edno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Casanova-Moll\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Escoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrl.2016.05.008_bib0170","unstructured":"Asociaci\u00f3n Espa\u00f1ola contra el C\u00e1ncer (AECC 2015) [consultado 27 Ener 2013]. Disponible en: https:\/\/www.aecc.es\/SobreElCancer\/CancerPorLocalizacion\/mielomamultiple\/Paginas\/incidencia.aspx"},{"key":"10.1016\/j.nrl.2016.05.008_bib0175","unstructured":"Alegre A. Libro blanco del mieloma m\u00faltiple en Espa\u00f1a 2004. Madrid: Fundaci\u00f3n leucemia y linfoma, Novartis Farmac\u00e9utica S.A.; 2005."},{"key":"10.1016\/j.nrl.2016.05.008_bib0180","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0213-4853(10)70036-0","article-title":"Chemotherapy-induced peripheral neuropathy: An unresolved issue. Review","volume":"25","author":"Velasco","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2016.05.008_bib0185","first-page":"273","volume":"54","author":"H\u00f6ke","year":"2014","journal-title":"Rodent models of chemotherapy-induced peripheral neuropathy."},{"key":"10.1016\/j.nrl.2016.05.008_bib0190","first-page":"430","volume":"27","author":"Al\u00e9","year":"2015","journal-title":"Toxic effects of bortezomib on primary sensory neurons and Schwann cells of adult mice."},{"key":"10.1016\/j.nrl.2016.05.008_bib0195","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1526-4637.2006.00220.x","article-title":"Chronic pain in the cancer survivor: A new frontier","volume":"8","author":"Burton","year":"2007","journal-title":"Pain Med."},{"key":"10.1016\/j.nrl.2016.05.008_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2217\/pmt.15.19","article-title":"Mechanisms involved in the development of chemotherapy-induced neuropathy","volume":"5","author":"Boyette-Davis","year":"2015","journal-title":"Pain Manag."},{"key":"10.1016\/j.nrl.2016.05.008_bib0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00540-015-2077-x","article-title":"The possible involvement of JNK activation in the spinal dorsal horn in bortezomib-induced allodynia: The role of TNF-\u03b1 and IL-1\u03b2","volume":"30","author":"Li","year":"2016","journal-title":"J Anesth."},{"key":"10.1016\/j.nrl.2016.05.008_bib0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbi.2015.11.012","article-title":"Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells","volume":"55","author":"Ajmone-Cat","year":"2016","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.nrl.2016.05.008_bib0215","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuro.2014.02.001","article-title":"Neurotoxicity induced by antineoplastic proteasome inhibitors","volume":"43","author":"Al\u00e9","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nrl.2016.05.008_bib0220","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fphar.2013.00156","article-title":"Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)","volume":"4","author":"Han","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nrl.2016.05.008_bib0225","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.3109\/10428194.2010.483303","article-title":"Peripheral neuropathy during bortezomib treatment of multiple myeloma: A review of recent studies","volume":"51","author":"Cavaletti","year":"2010","journal-title":"Leuk Lymphoma."},{"key":"10.1016\/j.nrl.2016.05.008_bib0230","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.0b013e3181d5279e","article-title":"Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo controlled trial","volume":"74","author":"Pace","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nrl.2016.05.008_bib0235","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4040\/jkan.2015.45.5.661","article-title":"Disturbance in ADL from Chemotherapy-induced peripheral neuropathy and quality of life in cancer patients: The mediating effect of psychological distress","volume":"45","author":"Kim","year":"2015","journal-title":"J Korean Acad Nurs"},{"key":"10.1016\/j.nrl.2016.05.008_bib0240","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ygyno.2014.09.016","article-title":"Chemotherapy-induced peripheral neuropathy and its impact on health-related quality of life among ovarian cancer survivors: Results from the population-based PROFILES registry","volume":"135","author":"Ezendam","year":"2014","journal-title":"Gynecol Oncol."},{"key":"10.1016\/j.nrl.2016.05.008_bib0245","first-page":"971","article-title":"Medical treatment of neuropathic pain","volume":"133","author":"Slapo","year":"2013","journal-title":"Tidsskr Nor Laegeforen."},{"key":"10.1016\/j.nrl.2016.05.008_bib0250","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000435932","article-title":"Cytokines in neuropathic pain and associated depression","volume":"30","author":"Lees","year":"2015","journal-title":"Mod Trends Pharmaco Psychiatri."},{"key":"10.1016\/j.nrl.2016.05.008_bib0255","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00520-013-1766-y","article-title":"Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): A University of Rochester CCOP study","volume":"21","author":"Gewandter","year":"2013","journal-title":"Support Care Cancer."},{"key":"10.1016\/j.nrl.2016.05.008_bib0260","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1526-4637.2006.00222.x","article-title":"The social consequences for older people of neuropathic pain: A qualitative study","volume":"8","author":"Sofaer-Bennett","year":"2007","journal-title":"Pain Med."},{"key":"10.1016\/j.nrl.2016.05.008_bib0265","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3111\/13696998.2012.729548","article-title":"The burden associated with neuropathic pain in Western Europe","volume":"16","author":"Langley","year":"2013","journal-title":"J Med Econ."},{"key":"10.1016\/j.nrl.2016.05.008_bib0270","unstructured":"Worl Health Organitation (WHO). Who handbook for reporting results of c\u00e1ncer treatment. Geneva: World Healt Organitation, Who offset publication; no. 48, 45p.1979 [consultado 13 Feb 2013]. Disponible en: http:\/\/www.who.int\/iris\/handle\/10665\/37200."},{"key":"10.1016\/j.nrl.2016.05.008_bib0275","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1157\/13093266","article-title":"Linguistic adaptation and Spanish validation of the LANSS (Leeds Assessment of Neuropathic Symptoms and Signs) scale for the diagnosis of neuropathic pain","volume":"127","author":"P\u00e9rez","year":"2006","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.nrl.2016.05.008_bib0280","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1477-7525-5-66","article-title":"Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component","volume":"5","author":"Perez","year":"2007","journal-title":"Health Qual Life Outcomes."},{"key":"10.1016\/j.nrl.2016.05.008_bib0285","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0025-7753(03)73601-X","article-title":"Validaci\u00f3n espa\u00f1ola del cuestionario Brief Pain Inventory en pacientes con dolor de causa neopl\u00e1sica","volume":"120","author":"Badia","year":"2003","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.nrl.2016.05.008_bib0290","first-page":"138","article-title":"Adaptaci\u00f3n transcultural a la poblaci\u00f3n espa\u00f1ola de la escala de incapacidad por dolor lumbar de Oswestry","volume":"29","author":"Fl\u00f3rez Garc\u00eda","year":"1995","journal-title":"Rehabilitaci\u00f3n (Madr)."},{"key":"10.1016\/j.nrl.2016.05.008_bib0295","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0048-7120(06)74881-2","article-title":"Escala de incapacidad por dolor lumbar de Oswestry","volume":"40","author":"Alc\u00e1ntara-Bumbiedro","year":"2006","journal-title":"Rehabilitaci\u00f3n."},{"key":"10.1016\/j.nrl.2016.05.008_bib0300","unstructured":"Informe t\u00e9cnico de la Agencia de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias (AETS) del Instituto de Salud Carlos III del Ministerio de Sanidad y Consumo. \u00cdndices y escalas utilizados en ciertas tecnolog\u00edas de la prestaci\u00f3n ortoprot\u00e9sica. Publicaci\u00f3n N.\u00b0 33 Madrid, noviembre del 2002 [consultado 22 Nov 2015]. Disponible en: http:\/\/gesdoc.isciii.es\/gesdoccontroller?action=download&id=07\/11\/2012-c27c8b55c2"},{"key":"10.1016\/j.nrl.2016.05.008_bib0305","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.33588\/rn.3911.2004447","article-title":"Escalas espec\u00edficas para la evaluaci\u00f3n de la calidad de vida en el ictus","volume":"39","author":"Carod-Artal","year":"2004","journal-title":"Rev Neurol"},{"key":"10.1016\/j.nrl.2016.05.008_bib0310","unstructured":"Giraldo P, L\u00f3pez L, Palomera L. Gu\u00eda Cl\u00ednica y protocolo de actuaci\u00f3n en el tratamiento del mieloma m\u00faltiple. Utilizaci\u00f3n de bortezomib (Velcade\u00ae), mayo del 2005, p. 12 [consultado 16 Mar 2014] Disponible en: http:\/\/www.fehha.org\/pub\/publicaciones\/docs\/guia_MM.pdf"},{"key":"10.1016\/j.nrl.2016.05.008_bib0315","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/WCO.0b013e32835804c5","article-title":"Small fibre neuropathy","volume":"25","author":"Lauria","year":"2012","journal-title":"Curr Opin Neurol."},{"key":"10.1016\/j.nrl.2016.05.008_bib0320","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.pain.2010.11.012","article-title":"On the relationship between nociceptive evoked potentials and skin biopsy in small fiber neuropathies","volume":"152","author":"Casanova-Molla","year":"2011","journal-title":"Pain."},{"key":"10.1016\/j.nrl.2016.05.008_bib0325","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: A comprehensive review of the literature","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood."},{"key":"10.1016\/j.nrl.2016.05.008_bib0330","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11912-007-0036-x","article-title":"Chemotherapy-induced neuropathy","volume":"9","author":"Bhagra","year":"2007","journal-title":"Curr Oncol Rep."}],"container-title":["Neurolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316300846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213485316300846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T09:15:52Z","timestamp":1749028552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213485316300846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0213485316300846"],"URL":"https:\/\/doi.org\/10.1016\/j.nrl.2016.05.008","relation":{},"ISSN":["0213-4853"],"issn-type":[{"type":"print","value":"0213-4853"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dolor neurop\u00e1tico en pacientes oncol\u00f3gicos en tratamiento con bortezomib","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrl.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}